{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:37:14Z","timestamp":1788377834163,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100002108","name":"Friedreich's Ataxia Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12883-016-0526-2","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T19:24:19Z","timestamp":1452540259000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Friedreich Ataxia and nephrotic syndrome: a series of two patients"],"prefix":"10.1186","volume":"16","author":[{"given":"Julianna E.","family":"Shinnick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Vivaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Schadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,12]]},"reference":[{"issue":"9","key":"526_CR1","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1177\/0883073812448230","volume":"27","author":"MB Delatycki","year":"2012","unstructured":"Delatycki MB, Corben LA. Clinical features of Fredreich Ataxia. J Child Neurol. 2012;27(9):1133\u20137.","journal-title":"J Child Neurol"},{"issue":"1","key":"526_CR2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.0b013e318297ef18","volume":"81","author":"LA Corben","year":"2013","unstructured":"Corben LA, Ho M, Copland J, Tai G, Delatycki MB. Increased prevalence of sleep-disordered breathing in Friedreich ataxia. Neurology. 2013;81(1):46\u201351.","journal-title":"Neurology"},{"issue":"9","key":"526_CR3","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s00415-013-6978-z","volume":"260","author":"LA Seyer","year":"2013","unstructured":"Seyer LA, Galetta K, Wilson J, Sakai R, Perlman S, Mathews K, et al. Analysis of the visual system in Friedreich ataxia. J Neurol. 2013;260(9):2362\u20139.","journal-title":"J Neurol"},{"issue":"2","key":"526_CR4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1096-8628(19991119)87:2<168::AID-AJMG8>3.0.CO;2-2","volume":"87","author":"MB Delatycki","year":"1999","unstructured":"Delatycki MB, Paris DB, Gardner RJ, Nicholson GA, Nassif N, Storey E, et al. Clinical and genetic study of Friedreich ataxia in an Australian population. Am J Med Genet. 1999;87(2):168\u201374.","journal-title":"Am J Med Genet"},{"issue":"1\u20132","key":"526_CR5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jns.2014.04.015","volume":"342","author":"NR Greeley","year":"2014","unstructured":"Greeley NR, Regner S, Willi S, Lynch DR. Cross-sectional analysis of glucose metabolism in Friedreich ataxia. J Neurol Sci. 2014;342(1\u20132):29\u201335.","journal-title":"J Neurol Sci"},{"issue":"4","key":"526_CR6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000255341","volume":"15","author":"G Rance","year":"2010","unstructured":"Rance G, Corben L, Barker E, Carew P, Chisari D, Rogers M, et al. Auditory perception in individuals with Friedreich\u2019s ataxia. Audiol Neurooto. 2010;15(4):229\u201340.","journal-title":"Audiol Neurooto"},{"issue":"6","key":"526_CR7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1586\/erc.12.57","volume":"10","author":"DR Lynch","year":"2012","unstructured":"Lynch DR, Regner SR, Schadt KA, Friedman LS, Lin KY, St John Sutton MG. Management and therapy for cardiomyopathy in Fridreich\u2019s ataxia. Expert Rev Cardiovasc Ther. 2012;10(6):767\u201377.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"S1","key":"526_CR8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/jnc.12317","volume":"126","author":"MH Parkinson","year":"2013","unstructured":"Parkinson MH, Boesch S, Nachbauer W, Mariotti C, Giunti P. Features of Friedreich\u2019s ataxia: clinical and atypical phenotypes. J Neurochem. 2013;126(S1):103\u201317.","journal-title":"J Neurochem"},{"issue":"6","key":"526_CR9","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/hmg\/9.6.887","volume":"9","author":"H Puccio","year":"2000","unstructured":"Puccio H, K\u0153nig M. Recent advances in the molecular pathogenesis of Friedreich ataxia. Hum Mol Genet. 2000;9(6):887\u201392.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"526_CR10","doi-asserted-by":"crossref","first-page":"e20666","DOI":"10.1371\/journal.pone.0020666","volume":"6","author":"J Garc\u00eda-Gim\u00e9nez","year":"2011","unstructured":"Garc\u00eda-Gim\u00e9nez J, Gimeno A, Gonzalez-Cabo P, Das\u00ed F, Bolinches-Amor\u00f3s A, Moll\u00e1 B. Differential expression of PGC-1alpha and metabolic sensors suggest age-dependent induction of mitochondrial biogenesis in Friedreich ataxia fibroblasts. PLoS One. 2011;6(6):e20666.","journal-title":"PLoS One"},{"issue":"4","key":"526_CR11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/14734220600913246","volume":"5","author":"S Michael","year":"2006","unstructured":"Michael S, Petrocine SV, Qian J, Lamarche JB, Knutson MD, Garrick MD, et al. Iron and iron-responsive proteins in the cardiomyopathy of Friedreich\u2019s ataxia. Cerebellum. 2006;5(4):257\u201367.","journal-title":"Cerebellum"},{"issue":"3","key":"526_CR12","doi-asserted-by":"crossref","first-page":"e0116396","DOI":"10.1371\/journal.pone.0116396","volume":"10","author":"AH Koeppen","year":"2006","unstructured":"Koeppen AH, Ramirez RL, Becker AB, Bjork ST, Levi S, Santambrogio P, et al. The pathogenesis of cardiomyopathy in Friedreich ataxia. PLoS. 2006;10(3):e0116396.","journal-title":"PLoS"},{"issue":"8","key":"526_CR13","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1586\/14737175.2014.939173","volume":"14","author":"CJ Strawser","year":"2014","unstructured":"Strawser CJ, Schadt KA, Lynch DR. Therapeutic approaches for the treatment of Friedreich\u2019s ataxia. Expert Rev Neurother. 2014;14(8):947\u201355.","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"526_CR14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/ane.12337","volume":"132","author":"L Seyer","year":"2015","unstructured":"Seyer L, Greeley N, Foerster D, Strawser C, Gelbard S, Dong Y, et al. Open-label pilot study of interferon gamma-1b in Friedreich ataxia. Acta Neurol Scand. 2015;132(1):7\u201315.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"526_CR15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/S0317167100042852","volume":"8","author":"GV Watters","year":"1981","unstructured":"Watters GV, Zlotkin SH, Kaplan BS, Humphreys P, Drummond KN. Friedreich\u2019s ataxia with nephrotic syndrome and convulsive disorder: clinical and neurophysiological studies with renal and nerve biopsies and an autopsy. Can J Neurol Sci. 1981;8(1):55\u201360.","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"526_CR16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ddrr.108","volume":"16","author":"CM Quinzii","year":"2010","unstructured":"Quinzii CM, Hirano M. Coenzyme Q and mitochondrial disease. Dev Disabil Res Rev. 2010;16(2):183\u20138.","journal-title":"Dev Disabil Res Rev"},{"issue":"9","key":"526_CR17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00467-005-1948-z","volume":"20","author":"E Mart\u00edn-Hern\u00e1ndez","year":"2005","unstructured":"Mart\u00edn-Hern\u00e1ndez E, Garc\u00eda-Silva MT, Vara J, Campos Y, Cabello A, Muley R, et al. Renal pathology in children with mitochondrial diseases. Pediatr Nephrol. 2005;20(9):183\u20138.","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"526_CR18","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1177\/0883073812448462","volume":"27","author":"SR Regner","year":"2012","unstructured":"Regner SR, Wilcox NS, Friedman LS, Seyer LA, Schadt KA, Brigatti KW, et al. Friedreich ataxia clinical outcome measures: natural history evaluation in 410 participants. J Child Neurol. 2012;27(9):1152\u20138.","journal-title":"J Child Neurol"},{"issue":"4","key":"526_CR19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00467-011-1926-6","volume":"27","author":"F Emma","year":"2012","unstructured":"Emma F, Bertini E, Salviati L, Montini G. Renal involvement in mitochondrial cytopathies. Pediatr Nephrol. 2012;27(4):539\u201350.","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"526_CR20","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1172\/JCI69000","volume":"123","author":"S Ashraf","year":"2013","unstructured":"Ashraf S, Gee HY, Woerner S, Xie LX, Vega-Warner V, Lovric S, et al. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Invest. 2013;123(12):5179.","journal-title":"J Clin Invest"},{"issue":"s1","key":"526_CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/jnc.12303","volume":"126","author":"P Gonz\u00e1lez\u2010Cabo","year":"2013","unstructured":"Gonz\u00e1lez\u2010Cabo P, Palau F. Mitochondrial pathophysiology in Friedreich\u2019s ataxia. J Neurochem. 2013;126(s1):53\u201364.","journal-title":"J Neurochem"},{"issue":"5319","key":"526_CR22","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.276.5319.1709","volume":"276","author":"M Babcock","year":"1997","unstructured":"Babcock M, de Silva D, Oaks R, Davis-Kaplan S, Jiralerspong S, Montermini L, et al. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science. 1997;276(5319):1709\u201312.","journal-title":"Science"},{"issue":"2","key":"526_CR23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/84818","volume":"27","author":"H Puccio","year":"2001","unstructured":"Puccio H, Simon S, Coss\u00e9e M, Criqui-Filipe P, Tiziano F, Melki J. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet. 2001;27(2):181\u20136.","journal-title":"Nat Genet"},{"issue":"2","key":"526_CR24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ng1097-215","volume":"17","author":"A Rotig","year":"1997","unstructured":"Rotig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet. 1997;17(2):215\u20137.","journal-title":"Nat Genet"},{"key":"526_CR25","author":"M Pane","year":"2015","unstructured":"Pane M, Fanelli L, Mazzone ES, Olivieri G, D\u2019Amico A, Messina S, et al. Benefits of glucocorticoids in non-ambulant boys\/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test. Neuromuscul Disord. 2015. doi: 10.1016\/j.nmd.2015.07.009 .","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"526_CR26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/187153012799279045","volume":"12","author":"EK Reeves","year":"2012","unstructured":"Reeves EK, Rayavarapu S, Damsker JM, Nagaraju K. Glucocorticoid analogues: potential therapeutic alternatives for treating inflammatory muscle diseases. Endocr Metab Immune Disord Drug Targets. 2012;12(1):95\u2013103.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"4","key":"526_CR27","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1468-1331.2010.03203.x","volume":"18","author":"T Broccoletti","year":"2011","unstructured":"Broccoletti T, Del Giudice E, Cirillo E, Vigliano I, Giardino G, Ginocchio VM, et al. Efficacy of very-low-dose betamethasone on neurological symptoms in ataxia-telangiectasia. Eur J Neurol. 2011;18(4):564\u201370.","journal-title":"Eur J Neurol"},{"key":"526_CR28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.freeradbiomed.2014.04.016","volume":"73","author":"E Obis","year":"2014","unstructured":"Obis E, Irazusta V, Sanchis D, Ros J, Tamarit J. Frataxin deficiency in neonatal rat ventricular myocytes targets mitochondria and lipid metabolism. Free Radic Biol Med. 2014;73:21\u201333.","journal-title":"Free Radic Biol Med"},{"issue":"14","key":"526_CR29","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1093\/hmg\/ddq183","volume":"19","author":"JA Navarro","year":"2010","unstructured":"Navarro JA, Ohmann E, Sanchez D, Botella JA, Liebisch G, Molt\u00f3 MD, et al. Altered lipid metabolism in a Drosophila model of Friedreich\u2019s ataxia. Hum Mol Genet. 2010;19(14):2828\u201340.","journal-title":"Hum Mol Genet"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-016-0526-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T10:10:53Z","timestamp":1526638253000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2377\/16\/3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["526"],"URL":"https:\/\/doi.org\/10.1186\/s12883-016-0526-2","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,12]]},"article-number":"3"}}